NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.52% | -142.06% | 180.53% | 119.26% | -27.46% |
| Total Depreciation and Amortization | 7.98% | 1.37% | -14.08% | 0.71% | -14.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.00% | 384.37% | -664.96% | -272.24% | 171.34% |
| Change in Net Operating Assets | -106.52% | -69.99% | -137.30% | -586.82% | 16.98% |
| Cash from Operations | -16.84% | -227.30% | 5.35% | -117.57% | 3.45% |
| Capital Expenditure | -- | -- | -- | -236.36% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -166.67% | -- | -- | 0.00% | 99.20% |
| Cash from Investing | -18,400.00% | -12,666.67% | -- | -208.00% | 99.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -100.00% | 100.00% |
| Issuance of Common Stock | -100.00% | -- | -92.09% | 25,912.50% | -95.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 100.00% | -92.36% | 688.28% | 650.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.21% | -239.95% | -925.00% | -94.12% | 2,142.11% |